Objective Analysis of Caesarean Scar Pregnancy
The Predictive Value of an Ultrasound Quantitative Scoring System for Treatment Method Selection in Patients With Caesarean Scar Pregnancy: A Single-Centre Retrospective Study
1 other identifier
observational
117
1 country
1
Brief Summary
This study uses a systematic scoring method combined with clinical and ultrasound data to comprehensively evaluate patient conditions and explore the guiding value of the ultrasound quantitative scoring system for selecting the surgical approach for caesarean scar pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 23, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2022
CompletedFirst Submitted
Initial submission to the registry
January 25, 2024
CompletedFirst Posted
Study publicly available on registry
February 26, 2024
CompletedFebruary 26, 2024
February 1, 2024
3.9 years
January 25, 2024
February 17, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
intraoperative blood loss
The patient's blood loss during surgery. Check the blood volume in ml of the aspirator reservoir.
during surgery
length of hospital stay
Number of days the patient was hospitalized. Discharge assessment: vital signs stable, no abdominal pain, no active bleeding.
Within 1 week
serum β-HCG levels
The time taken for serum β-HCG levels to return to normal
Within 2 weeks after the operation
Study Arms (2)
low-risk group
high-risk group
Interventions
ultrasound-guided/hysteroscopic curettage
laparoscopic removal of the pregnancy lesion
Eligibility Criteria
A total of 117 patients with caesarean scar pregnancy admitted to the Obstetrics and Gynecology Inpatient Area of Chengde Central Hospital, China, from January 2019 to December 2022 were selected for this study.
You may qualify if:
- history of at least one previous caesarean section
- symptoms suggestive of caesarean scar pregnancy, such as unexplained abnormal vaginal bleeding, abdominal pain, cervical pain or abnormal uterine activity during pregnancy
- amenorrhea ≤84 days
- ultrasound examination suggesting a single gestational sac with intact morphology
- stable maternal vital signs
You may not qualify if:
- mass-type caesarean scar pregnancy
- previous medication or surgical treatment before ultrasound examination
- haemodynamically unstable patients
- patients with surgical contraindications
- incomplete or lost follow-up clinical data
- patients with severe medical conditions such as hypertension, diabetes, hyperthyroidism and haemophilia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chengde Central Hospital
Chengde, 067000, China
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- physician
Study Record Dates
First Submitted
January 25, 2024
First Posted
February 26, 2024
Study Start
January 18, 2019
Primary Completion
December 23, 2022
Study Completion
December 25, 2022
Last Updated
February 26, 2024
Record last verified: 2024-02